Clinical Trial Update: Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intensive uric acid lowering with verinurad and febuxostat in patients with albuminuria completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• Verinurad (verinurad)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperuricemia, Albuminuria | Phase 2 | Status: COMPLETED | Results posted: 2020-01-10